miscsubjectsAI governance
Evidence review

Retatrutide vs Tirzepatide: Human Trial Data on Weight Loss and Load Reduction

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `retatrutide-tirzepatide`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/retatrutide-tirzepatide

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-tirzepatide/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/retatrutide-tirzepatide/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/retatrutide-tirzepatide/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/retatrutide-tirzepatide/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Retatrutide might help you

  1. What keeps failing: Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.
  2. What Retatrutide is studied to do: Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.
  3. Therefore for you: If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.

Why Tirzepatide might help you

  1. What keeps failing: Same mechanical overload pattern as other GLP-1 contexts at higher body weight.
  2. What Tirzepatide is studied to do: Studied for GLP-1/GIP weight loss — load reduction on spine and joints.
  3. Therefore for you: If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.

How these fit together

Each compound above targets a different degeneration layer. Together they are a stack — not five copies of the same mechanism.

  • Retatrutide → metabolic load / body weight
  • Tirzepatide → metabolic load / body weight

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 2
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 3

Quantified confidence (this ledger): 0.31 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Triple–Hormone-Receptor Agonist Retatrutide for Obesity (source s1)

Phase 2 trial results for retatrutide weight loss.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Tirzepatide Once Weekly for the Treatment of Obesity (source s2)

SURMOUNT-1 tirzepatide weight loss data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Tirzepatide or Retatrutide?? — Reddit, r/RetatrutideTrial (source s3)

User anecdotes on switching and losses.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Tirzepatide · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 3 sources · swipe →chain b39e96949082 · verify chain · provenance
Evidence ledger 4 · tier-ranked · API
mechanistic
Each additional pound of body weight adds approximately 4 lb compressive force to the lumbar spine during walking.
humanlow confidence
Retatrutide 12 mg produced mean 24.2% weight loss at 48 weeks in phase 2 obesity trial versus 2.1% placebo.
sources: s1
humanlow confidence
Tirzepatide 15 mg produced mean 20.9% weight loss at 72 weeks in SURMOUNT-1 versus 3.1% placebo.
sources: s2
anecdotallow confidence
Reddit users report personal weight losses of 50-100 lb on these compounds with variable appetite effects between them.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 00:50
Retatrutide vs Tirzepatide: Human Trial Data on Weight Loss and Load Reduction · 4 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Retatrutide for Tirzepatide
Slug: retatrutide-tirzepatide
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"dual_compound","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"retatrutide","name":"Retatrutide"},{"id":"tirzepatide","name":"Tirzepatide"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_
it output
{
  "slug": "retatrutide-tirzepatide",
  "title": "Retatrutide vs Tirzepatide: Human Trial Data on Weight Loss and Load Reduction",
  "body": "## What's breaking down\n\nExcess body weight increases compressive forces across the spine, hips, knees and feet. Each extra pound of body mass adds roughly 4 pounds of load to the lumbar spine during walking. When body weight stays elevated, mechanical stress outpaces natural repair in load-bearing tissues. Both compounds are studied for effects on body weight through GLP-1 and related pathways; any benefit to joints or spine would come from reduced load rather than direct tissue regeneration.\n\n## Why Retatrutide might help you\n\n1. What keeps failing: Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\n2. What Retatrutide is studied to do: Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\n3. Therefore for you: If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\n\n## Why Tirzepatide might help you\n\n1. What keeps failing: Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\n2. What Tirzepatide is studied to do: Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\n3. Therefore for you: If that la
92265659b24fb1f0
Machine verification: /api/articles/retatrutide-tirzepatide/contributions
Ask this article · 7 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Each additional pound of body weight adds approximately 4 lb compressive force to the lumbar spine during walking."?
ask retatrutide-tirzepatide claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "Retatrutide 12 mg produced mean 24.2% weight loss at 48 weeks in phase 2 obesity trial versus 2.1% placebo."?
ask retatrutide-tirzepatide claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Tirzepatide 15 mg produced mean 20.9% weight loss at 72 weeks in SURMOUNT-1 versus 3.1% placebo."?
ask retatrutide-tirzepatide claim c2 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users report personal weight losses of 50-100 lb on these compounds with variable appetite effects between them."?
ask retatrutide-tirzepatide claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdotes on switching and losses."
ask retatrutide-tirzepatide source s3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Retatrutide vs Tirzepatide: Human Trial Data on Weight Loss and Load Reduction — and what would you need me to tell you first?
ask retatrutide-tirzepatide condition gaps · paste includes §SELF
What good and bad outcomes are documented for Retatrutide vs Tirzepatide: Human Trial Data on Weight Loss and Load Reduction (studies vs anecdotes)?
ask retatrutide-tirzepatide good bad experiences · paste includes §SELF
retatrutide-tirzepatide · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 20138 tokens · $0 · 2 models
chain head 5504295112672348
write grok/grok-4.3 · 2026-06-30 00:50 · 20138 tok · dcd5b77ea49b
voxel_divide owner · 2026-07-17 02:41 · tokens unrecorded · 550429511267
verify chain →
Live ledger · 10 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 18:13
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 16:58
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 12:31
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 11:16
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 10:15
JCI_CLASSIFY jci · HTTP 200 · 2026-07-19 06:56
view full ledger & cards →
REST + ledger
read GET /api/articles/retatrutide-tirzepatide · GET /api/articles/retatrutide-tirzepatide?format=post (the editable body)
create/replace POST /api/articles/retatrutide-tirzepatide · PUT /api/articles/retatrutide-tirzepatide (replace, keeps revision) · PATCH /api/articles/retatrutide-tirzepatide (merge)
delete DELETE /api/articles/retatrutide-tirzepatide
writes need header x-terminal-key
LLM bundle GET /api/articles/retatrutide-tirzepatide/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim retatrutide-tirzepatide|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →